4729-31-01 Definitions.

As used in this chapter of the Administrative Code:

(A) “Compounded sterile product prescription” shall have the same meaning as in rule 4729-19-01 of the Administrative Code.

(B) “Fluid therapy pharmacy” means a pharmacy where the primary purpose is to compound and dispense parenteral compounded sterile product prescriptions. Such a pharmacy must comply with the minimum standards for compounding parenteral or sterile product prescriptions as defined in rule 4729-19-04 of the Administrative Code.

Replaces: Replaces 4729-31-01

Effective: 01/01/2009

R.C. 119.032 review dates: 12/01/2013

Promulgated Under: 119.03

Statutory Authority: 3719.28, 4729.26

Rule Amplifies: 3719.01, 4729.01

Prior Effective Dates: 3/1/1999